EDGAR Filing Documents for 0001144204-10-015670

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001144204-10-015670

Filing Date

2010-03-25

Accepted

2010-03-25 17:03:58

Documents

Period of Report

2009-12-31

Document Format Files

Seq	Description	Document	Type	Size
1		v178368_10k.htm	10-K	2602747
2	GRAPHIC	chart.jpg	GRAPHIC	62148
3		v178368_ex21-1.htm	EX-21.1	10131
4		v178368_ex23-1.htm	EX-23.1	7203
5		v178368_ex23-2.htm	EX-23.2	15897
6		v178368_ex31-1.htm	EX-31.1	19092
7		v178368_ex31-2.htm	EX-31.2	17992
8		v178368_ex32-1.htm	EX-32.1	6516
9		v178368_ex32-2.htm	EX-32.2	6597
	Complete submission text file	0001144204-10-015670.txt		2773243

Mailing Address

Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965

KERYX BIOPHARMACEUTICALS INC (Filer) CIK: 0001114220 (see all company filings)